tiprankstipranks
Advertisement
Advertisement

PCCURIB Stock Latest News

Curi Bio Strengthens Role in Human-Relevant Drug Discovery Models
Private CompaniesCuri Bio Strengthens Role in Human-Relevant Drug Discovery Models
15h ago
CURIB
Curi Bio Targets West Coast Growth With New Regional Sales Role
PremiumPrivate Companies
Curi Bio Targets West Coast Growth With New Regional Sales Role
15h ago
CURIB
Curi Bio Targets Global Growth With Presence at World Muscle Society 2026
PremiumPrivate Companies
Curi Bio Targets Global Growth With Presence at World Muscle Society 2026
15h ago
CURIB
Curi Bio Showcases Human iPSC Muscle Models for Duchenne Drug Discovery
PremiumPrivate Companies
Curi Bio Showcases Human iPSC Muscle Models for Duchenne Drug Discovery
2d ago
CURIB
Curi Bio Showcases 3D Skeletal Muscle Platform at European Muscle Conference
PremiumPrivate Companies
Curi Bio Showcases 3D Skeletal Muscle Platform at European Muscle Conference
2d ago
CURIB
Curi Bio Highlights High-Throughput AAV Capsid Screening Capabilities
PremiumPrivate CompaniesCuri Bio Highlights High-Throughput AAV Capsid Screening Capabilities
5d ago
CURIB
Curi Bio Highlights Neuromuscular Junction Model Data With Potential R&D Applications
Premium
Private Companies
Curi Bio Highlights Neuromuscular Junction Model Data With Potential R&D Applications
7d ago
CURIB
Curi Bio Showcases Scalable 3D Skeletal Muscle Platform at European Muscle Conference
Premium
Private Companies
Curi Bio Showcases Scalable 3D Skeletal Muscle Platform at European Muscle Conference
13d ago
CURIB
Curi Bio Showcases 3D Human Tissue Platforms for Botulinum Toxin Testing at Global Bio Conference
PremiumPrivate Companies
Curi Bio Showcases 3D Human Tissue Platforms for Botulinum Toxin Testing at Global Bio Conference
15d ago
CURIB
Curi Bio Showcases 3D Neuromuscular Models for Neurotoxin Potency Testing
PremiumPrivate Companies
Curi Bio Showcases 3D Neuromuscular Models for Neurotoxin Potency Testing
16d ago
CURIB
Curi Bio Showcases 3D Tissue Platforms and APAC Expansion Efforts at CPHI Korea 2026
PremiumPrivate Companies
Curi Bio Showcases 3D Tissue Platforms and APAC Expansion Efforts at CPHI Korea 2026
16d ago
CURIB
Curi Bio Showcases 3D Muscle Tissue Platform at Korean Sarcopenia Congress
PremiumPrivate Companies
Curi Bio Showcases 3D Muscle Tissue Platform at Korean Sarcopenia Congress
19d ago
CURIB
Curi Bio Showcases 3D Muscle Tissue Platform at Korean Sarcopenia Congress
PremiumPrivate CompaniesCuri Bio Showcases 3D Muscle Tissue Platform at Korean Sarcopenia Congress
20d ago
CURIB
Curi Bio Explores Functional Screening Platform for AI-Designed AAV Capsids
Premium
Private Companies
Curi Bio Explores Functional Screening Platform for AI-Designed AAV Capsids
21d ago
CURIB
Curi Bio Highlights Non-Animal Potency Testing Capabilities at Global Bio Conference 2026
Premium
Private Companies
Curi Bio Highlights Non-Animal Potency Testing Capabilities at Global Bio Conference 2026
21d ago
CURIB
Curi Bio Targets Korean Biopharma Market With 3D Tissue Platforms and NAM-Focused Services
PremiumPrivate Companies
Curi Bio Targets Korean Biopharma Market With 3D Tissue Platforms and NAM-Focused Services
24d ago
CURIB
Curi Bio Platform Featured in AI-Driven Muscle Regeneration Research
PremiumPrivate Companies
Curi Bio Platform Featured in AI-Driven Muscle Regeneration Research
27d ago
CURIB
Curi Bio Showcases High-Throughput Cardiac Electrophysiology Workflow
PremiumPrivate Companies
Curi Bio Showcases High-Throughput Cardiac Electrophysiology Workflow
1M ago
CURIB
Curi Bio Showcases 3D Human Tissue Platforms to Drug Discovery Stakeholders
PremiumPrivate Companies
Curi Bio Showcases 3D Human Tissue Platforms to Drug Discovery Stakeholders
1M ago
CURIB
Curi Bio Expands Role in AI-Driven Muscle Research and 3D Human Tissue Models
PremiumPrivate CompaniesCuri Bio Expands Role in AI-Driven Muscle Research and 3D Human Tissue Models
1M ago
CURIB
Curi Bio’s Mantarray Platform Highlighted in AI-Driven Muscle Reprogramming Study
Premium
Private Companies
Curi Bio’s Mantarray Platform Highlighted in AI-Driven Muscle Reprogramming Study
1M ago
CURIB
Curi Bio Highlights 3D Human Tissue Models in Evolving Preclinical Research
Premium
Private Companies
Curi Bio Highlights 3D Human Tissue Models in Evolving Preclinical Research
1M ago
CURIB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >